LoadingLoadingLoadingThe quick read
Latest quote·Oct 16
Net selling: insiders sold $4.3M and bought $79K on the open market in 90 days (SEC Form 4). Congress: net selling of $1K to $15K in 180 days.
Analyst target and ratings are on paid plans
See the 12-month consensus target and the buy/hold/sell rating split.
Unlock the full resultsNet selling: insiders sold $4.3M and bought $79K of CME stock on the open market in the 90 days to Oct 18, 2026, according to SEC Form 4 filings. The largest was Duffy, Terrence A (Chairman and CEO), who sold $4.1M. The latest filing was on Sep 28, 2026.
Rep. Gilbert Cisneros (D) sold $1K to $15K on Jun 16, 2026, disclosed 16 days later. In total, 1 member disclosed 1 CME trade with trade dates in the last 180 days, filed a median 16 days after trading.
This summary uses filings available on Oct 18, 2026. Insiders must report trades to the SEC within 2 business days, members of Congress have up to 45 days to disclose a trade, and funds file 13F holdings up to 45 days after each quarter ends, so the latest moves may not be public yet.
8 funds hold a position and insiders have been net selling.
Buys/Adds (3)
Qube Research
$301.8M
added
D.E. Shaw
$251.4M
added
Citadel
$222.0M
added
Sells (1)
No tracked top-trader positions in CME right now.
Live Hyperliquid positioning - not every stock is covered
Last report
Jul 22, 2026
Financial period
Q2 2026
Adjusted EPS
$2.91 expected
Revenue
No comparable estimate
| Period ending | Reported | EPS / estimate | EPS surprise | Revenue / estimate | Rev. surprise |
|---|---|---|---|---|---|
| Jun 30, 2026 | Jul 22, 2026 | $2.99 / $2.91Yahoo Finance | +2.75% beat | $1.71B / Unavailable | Unavailable |
| Mar 31, 2026 | Apr 22, 2026 | $3.36 / $3.37Yahoo Finance | -0.25% in line | Unavailable | Unavailable |
| Dec 31, 2025 | Feb 4, 2026 | $2.77 / $2.74Yahoo Finance | +0.99% in line | Unavailable | Unavailable |
| Sep 30, 2025 | Oct 22, 2025 | $2.68 / $2.63Yahoo Finance | +1.98% beat | Unavailable | Unavailable |
| Jun 30, 2025 | Jul 23, 2025 | $2.96 / $2.92Alpha Vantage | +1.37% beat | Unavailable | Unavailable |
| Mar 31, 2025 | Apr 23, 2025 | $2.80 / $2.81Alpha Vantage | -0.36% in line | Unavailable | Unavailable |
| Dec 31, 2024 | Feb 12, 2025 | $2.52 / $2.45Alpha Vantage | +3.05% beat | Unavailable | Unavailable |
| Sep 30, 2024 | Oct 23, 2024 | $2.68 / $2.65Alpha Vantage | +1.13% beat | Unavailable | Unavailable |
EPS uses Yahoo Finance where available, then Alpha Vantage or verified release comparisons. Revenue uses company releases and saved estimates.
Estimates as of Oct 17, 2026
EPS expected
$2.90 to $3.07
Revenue expected
10 analysts
Last 30 days
Analysts raising estimates
Estimate drift
Change in 30 days
| USD | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
| What came in | ||||
| Revenue | $1.54B | $1.65B | $1.88B | $1.71B |
| Cost of what it sold | $237.6M | $241.1M | $223.0M | $524.7M |
| Gross profit | $1.30B | $1.41B | $1.66B | $1.18B |
| What it spent | ||||
| Sales and admin | $36.7M | $47.9M | $28.2M | $29.1M |
| Other operating costs | $290.7M | $340.1M | $319.2M | $45.3M |
| Total operating expenses | $327.4M | $388.0M | $347.4M | $74.4M |
| What was left | ||||
| Operating profit | $972.6M | $1.02B | $1.31B | $1.11B |
| Interest on debt | $44.0M | $43.7M | $43.6M | $43.6M |
| Profit before tax | $1.18B | $1.58B | $1.51B | $1.33B |
| Tax | $269.0M | $410.4M | $356.6M | $285.9M |
| Net profit | $908.0M | $1.17B | $1.15B | $1.04B |
| EBITDA | $1.30B | $1.65B | $1.64B | $946.5M |
This stock is in a strong uptrend, and looks overbought after a fast run-up.
Trend
Strong uptrend
85 / 100
RSI 14
20D volatility
52-week range
20D support
20D resistance
Returns
Price vs moving averages
Volume pace
Coverage leans bullish
Ingersoll Rand Inc. (IR) Stock forecasts
Leans bullishOct 15A new player in cattle futures? Analyst says ICE aims to challenge CME trading
NeutralOct 15Repligen Corporation (RGEN) Stock Forecasts
NeutralOct 15Cboe Global Markets (CBOE) Draws Fresh Earnings Interest, Is The Valuation Already Above Fair Value?
NeutralOct 15Financial Services Roundup: Market Talk
Leans bearishOct 14CME Group shares may move 3.2% on Oct. 21 earnings report
NeutralOct 14CME Group shares may move 3.2% on Oct. 21 earnings report
NeutralOct 14CME Group shares may move 3.2% on Oct. 21 earnings report
NeutralOct 14